THE PENNANT GROUP, INC. Impairment of Long-Lived Assets Held-for-use
THE PENNANT GROUP, INC. (PNTG) reported Impairment of Long-Lived Assets Held-for-use of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2026-02-26
- THE PENNANT GROUP, INC. impairment of long-lived assets held-for-use for the quarter ending 2023-12-31 was $0.00.
- THE PENNANT GROUP, INC. impairment of long-lived assets held-for-use for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- THE PENNANT GROUP, INC. impairment of long-lived assets held-for-use for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- THE PENNANT GROUP, INC. impairment of long-lived assets held-for-use for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- THE PENNANT GROUP, INC. impairment of long-lived assets held-for-use for fiscal 2025 was $0.00.
- THE PENNANT GROUP, INC. impairment of long-lived assets held-for-use for fiscal 2024 was $0.00.
- THE PENNANT GROUP, INC. impairment of long-lived assets held-for-use for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- THE PENNANT GROUP, INC. impairment of long-lived assets held-for-use for fiscal 2022 was $218.00K, a 92.31% decline from fiscal 2021.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 6 month | Impairment of Long-Lived Assets Held-for-use 9 month | Impairment of Long-Lived Assets Held-for-use 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | $0.00 derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $0.00 derived: sum of 3 quarters · filed 2023-08-08 | $4.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 | $0.00 derived: sum of 2 quarters · filed 2023-05-04 | $4.00K derived: sum of 3 quarters · filed 2023-11-07 | $121.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $4.00K derived: sum of 2 quarters · filed 2023-11-07 | $121.00K derived: sum of 3 quarters · filed 2023-11-07 | $218.00K 10-K · filed 2023-02-23 |
| 2022-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $121.00K derived: sum of 2 quarters · filed 2023-11-07 | $218.00K 10-Q · filed 2023-11-07 | $3.05M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $117.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $214.00K 10-Q · filed 2023-08-08 | $3.05M derived: sum of 3 quarters · filed 2023-08-08 | $3.05M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $97.00K 10-Q · filed 2023-05-04 | $2.93M derived: sum of 2 quarters · filed 2023-05-04 | $2.93M derived: sum of 3 quarters · filed 2023-05-04 | $2.93M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $2.83M derived: sum of 2 quarters · filed 2023-02-23 | $2.83M derived: sum of 3 quarters · filed 2023-02-23 | $2.83M 10-K · filed 2023-02-23 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $0.00 derived: sum of 2 quarters · filed 2022-11-07 | $0.00 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-23 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |